Sarepta Therapeutics (SRPT) Asset Writedowns and Impairment (2010)
Sarepta Therapeutics (SRPT) recorded quarterly Asset Writedowns and Impairment of $7000.0 in Q4 2010.
Sarepta Therapeutics (SRPT) Asset Writedowns and Impairment (2010) Analysis & Trends
Sarepta Therapeutics' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $7000.0 for Q4 2010.
- In Q4 2010, Asset Writedowns and Impairment changed N/A year-over-year to $7000.0; the TTM figure through Mar 2012 stood at $7000.0 (changed N/A YoY), while the FY2025 annual figure was $165.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $7000.0 for Q4 2010 at Sarepta Therapeutics.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $7000.0 in Q4 2010 to a low of $7000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 7,000.00 |
| Dec 31, 2010 | 7,000.00 |